These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1867735)

  • 1. Improvement of phase III psychotropic drug trials by intensive phase II work.
    Klein DF
    Neuropsychopharmacology; 1991 Jun; 4(4):251-8; discussion 259-71. PubMed ID: 1867735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B; Angst J
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for clinical trials of psychotropic drugs June 1, 1977.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jul; 10(4):205-31. PubMed ID: 360242
    [No Abstract]   [Full Text] [Related]  

  • 5. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective response criteria in phase II and phase III studies.
    Jones WG; Akaza H; Van Oosterom AT; Kotake T
    Prog Clin Biol Res; 1988; 269():243-60. PubMed ID: 3293063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for the use of placebo controls in clinical trials of psychopharmacologic agents. Loma Linda University Institutional Review Board.
    Orr RD
    Psychiatr Serv; 1996 Nov; 47(11):1262-4. PubMed ID: 8916249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Planning of psychotropic drug trials. Seminar at Jongny, Switzerland, 16-18 March 1977].
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):105-204. PubMed ID: 30097
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical evaluation of psychopharmaceuticals in internal and general medicine. Elements for continuing psychopharmacologic and research education of the primary care physician].
    Castillo Pérez P
    An Med Interna; 1988 Sep; 5(9):471-81. PubMed ID: 2856628
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic drugs and paediatrics: a critical need for more clinical trials.
    Tishler CL; Reiss NS
    J Med Ethics; 2012 Apr; 38(4):250-2. PubMed ID: 22048850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-blind analysis and other video-strategies in phase II trials of psychotropic drugs.
    Müller-Oerlinghausen B; Renfordt E
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):99-103. PubMed ID: 7380587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some problems in the conduct of psychotropic drug trials (a review).
    Doongaji DR; Parikh MD
    J Postgrad Med; 1983 Apr; 29(2):67-74. PubMed ID: 6631765
    [No Abstract]   [Full Text] [Related]  

  • 17. The necessity of placebo application in psychotropic drug trials.
    Benkert O; Maier W
    Pharmacopsychiatry; 1990 Sep; 23(5):203-5. PubMed ID: 2251299
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical factors that may confound the assessment of drug efficacy.
    Csernansky JG; Newcomer JW; Miller LS; Faustman WO
    Psychopharmacol Bull; 1991; 27(3):231-5. PubMed ID: 1775593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.